Brightpath Diagnostics Inc
New York City, New York
Find prospects like Brightpath Diagnostics Inc
Get a list of similar companies, matched by industry, size and location, ready for outreach.
Free sample of 25 companies by email within one business day. No spam: we only use your email for this request.
About Brightpath Diagnostics Inc
Brightpath Diagnostics Inc is a company based in New York City, New York, United States, employing 1-5 people, reporting $0M-$1M in annual revenue and classified under Medical and Diagnostic Laboratories.
Its primary NAICS classification is 621511 (Medical Laboratories). Brightpath Diagnostics Inc is one of 5,245,681 companies listed in New York.
Business Contact Information
- Address
- 225 W 39th St, New York City, New York, 10018, United States
Industry & Classification
NAICS Codes
- 62Health Care and Social Assistance
- 6215Medical and Diagnostic Laboratories
- 621511Medical Laboratories
SIC Codes
- 80Health Services
- 807Medical And Dental Laboratories
- 8071Medical Laboratories
Company Details
- Employees
- 3 (1-5)
- Annual Revenue
- $242,000 ($0M-$1M)
Brightpath Diagnostics Inc: frequently asked questions
What does Brightpath Diagnostics Inc do?
Brightpath Diagnostics Inc is a company based in New York City, New York, United States, employing 1-5 people, reporting $0M-$1M in annual revenue and classified under Medical and Diagnostic Laboratories.
Where is Brightpath Diagnostics Inc located?
Brightpath Diagnostics Inc is headquartered at 225 W 39th St, New York City, New York, 10018, United States.
How many employees does Brightpath Diagnostics Inc have?
Brightpath Diagnostics Inc has about 3 employees (the 1-5 range).
What is Brightpath Diagnostics Inc's annual revenue?
Brightpath Diagnostics Inc's annual revenue is estimated at $242,000 (the $0M-$1M range).
What industry is Brightpath Diagnostics Inc in?
Brightpath Diagnostics Inc's primary NAICS code is 621511 (Medical Laboratories).
Largest companies in New York
Largest companies on Factur
Manufacturing sales in New York, 2026
In New York, Factur's 2026 study counted 53 manufacturing quotes worth $5M and 8 purchase orders over 12 months: 15% of quotes became orders, against 21% nationally. See the New York data.
Own this business?
Keep your profile accurate — or ask us to take it down. We acknowledge requests within 7 days and resolve them within 30 days.
Prefer email? privacy@facturmfg.com
Add this badge to your website — show visitors you're listed on Factur Data.